Clinical Trial Update: Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab with letrozole in postmenopausal women with progressive advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED